Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPyxis Oncology Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 6 | -$0.42 | -$0.32 | -$0.37 |
| Q2 2026 | 6 | -$0.44 | -$0.33 | -$0.38 |
| Q3 2026 | 3 | -$0.30 | -$0.30 | -$0.30 |
| Q4 2026 | 4 | -$0.30 | -$0.30 | -$0.30 |
| Q1 2027 | 2 | -$0.39 | -$0.39 | -$0.39 |
| Q2 2027 | 2 | -$0.39 | -$0.39 | -$0.39 |
| Q3 2027 | 2 | -$0.39 | -$0.39 | -$0.39 |
| Q4 2027 | 2 | -$0.39 | -$0.39 | -$0.39 |
| Q1 2028 | 3 | -$0.40 | -$0.40 | -$0.40 |
| Q2 2028 | 3 | -$0.39 | -$0.39 | -$0.39 |
| Q3 2028 | 3 | -$0.40 | -$0.40 | -$0.40 |
| Q4 2028 | 3 | -$0.40 | -$0.40 | -$0.40 |
Pyxis Oncology Inc Earnings Date And Information
Pyxis Oncology Inc last posted its earnings results on Monday, March 23rd, 2026. The company reported $-0.29 earnings per share for the quarter, topping analysts' consensus estimates of $-0.35 by $0.06. The company had revenue of 11.04 M for the quarter and had revenue of 13.86 M for the year. Pyxis Oncology Inc has generated $-1 earnings per share over the last year ($-1.28 diluted earnings per share) and currently has a price-to-earnings ratio of -1.67. Pyxis Oncology Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Pyxis Oncology Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/23/2026 | Q4 2025 | -$0.35 | -$0.29 | 0.06 | $125.00 K | $11.04 M |
| 11/03/2025 | Q3 2025 | -$0.36 | -$0.35 | 0.01 | $125.00 K | $0 |
| 08/14/2025 | Q2 2025 | -$0.36 | -$0.30 | 0.06 | $125.00 K | $2.82 M |
| 05/15/2025 | Q1 2025 | -$0.29 | -$0.35 | -0.06 | $125.00 K | $0 |
| 03/18/2025 | Q4 2024 | -$0.33 | -$0.58 | -0.25 | $100.00 K | $0 |
| 11/12/2024 | Q3 2024 | -$0.32 | -$0.35 | -0.03 | $100.00 K | $0 |
| 08/14/2024 | Q2 2024 | -$0.33 | -$0.29 | 0.04 | $100.00 K | $0 |
| 05/14/2024 | Q1 2024 | -$0.27 | -$0.06 | 0.21 | $4.13 M | $16.15 M |
| 03/21/2024 | Q4 2023 | -$0.49 | -$0.35 | 0.14 | N/A | $0 |
| 11/07/2023 | Q3 2023 | -$0.57 | -$0.56 | 0.01 | N/A | $0 |
| 08/11/2023 | Q2 2023 | -$0.66 | -$0.41 | 0.25 | N/A | $0 |
| 05/11/2023 | Q1 2023 | -$0.84 | -$0.50 | 0.34 | N/A | $0 |
| 05/10/2023 | Q4 2022 | N/A | $0.65 | N/A | N/A | $0 |
| 11/01/2022 | Q3 2022 | -$0.76 | -$0.83 | -0.07 | N/A | $0 |
| 08/15/2022 | Q2 2022 | -$0.68 | -$0.78 | -0.1 | N/A | $0 |
| 05/13/2022 | Q1 2022 | -$0.62 | -$0.97 | -0.35 | N/A | $0 |
| 03/29/2022 | Q4 2021 | -$0.37 | -$0.53 | -0.16 | N/A | $0 |
| 11/15/2021 | Q3 2021 | -$0.51 | -$0.45 | 0.06 | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$0.26 | N/A | N/A | $0 |
| 03/31/2021 | Q1 2021 | N/A | -$1.66 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Pyxis Oncology Inc Earnings: FAQ's
In the previous quarter, Pyxis Oncology Inc (:PYXS) reported $-0.29 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.35 by $0.06.
The conference call for Pyxis Oncology Inc's latest earnings report can be listened to online.
The conference call transcript for Pyxis Oncology Inc's latest earnings report can be read online.
Pyxis Oncology Inc (:PYXS) has a recorded annual revenue of $13.86 M.
Pyxis Oncology Inc (:PYXS) has a recorded net income of $-79,621,000.Pyxis Oncology Inc has generated $-1.28 earnings per share over the last four quarters.
Pyxis Oncology Inc (:PYXS) has a price-to-earnings ratio of -1.67 and price/earnings-to-growth ratio is 0.19.